Ke. Vancott et al., PHENOTYPIC AND GENOTYPIC STABILITY OF MULTIPLE LINES OF TRANSGENIC PIGS EXPRESSING RECOMBINANT HUMAN PROTEIN-C, Transgenic research, 6(3), 1997, pp. 203-212
Citations number
35
Categorie Soggetti
Biology,"Biochemical Research Methods","Biothechnology & Applied Migrobiology
The genotypic and phenotypic stability of four lines of transgenic pig
s expressing recombinant human protein C in milk was examined. Two lin
es were established with a construct consisting of a 2.6 kb mouse WAP
promoter and a 9.4 kb human protein C genomic DNA. Two lines were esta
blished with another construct consisting of a 4.1 kb mouse WAP promot
er and a 9.4 kb human protein C genomic DNA. Genotypic stability was m
easured by transgene copy number transmission. Outbred offspring havin
g a single transgene integration locus were established from a founder
having three independent, multicopy loci. Phenotypic stability over m
ultiple lactations was defined by the combination of recombinant human
protein C expression levels and the isoform signature of recombinant
human protein C in western blots. Both cDNA and genomic human protein
C transgenes gave similar ranges of expression levels of about 100-180
0 mu g ml(-1). Within a given outbred lineage having a single loci for
the cDNA transgene, the expression levels ranged between 100-400 mu g
ml(-1). Western blots of reduced recombinant protein C revealed that
single chain content was not dependent on expression level and was con
sistent within each transgenic line, but varied between transgenic lin
es. This suggests that native swine genetics may play a role in select
ion of production herds with optimal post-translational proteolytic pr
ocessing capability. Although swine are not conventional dairy livesto
ck, it is agreed that the short generation times, multiple offspring p
er litter, stable paternal transmission of the transgene, and milk pro
duction capabilities of swine offer distinct advantages over conventio
nal dairy livestock for the establishment of a herd producing a therap
eutic recombinant protein.